# SLE Digital Twin Living Requirements Specification (SLE-DT LRS)

## Revision Status
Literature Integrated Through:
1. SLE DEG Bioinformatics Review.
2. AI, Biomarkers, and Precision Rheumatology Review.
3. Digital Twins and the Metaverse in Healthcare Review.

---

## Document Purpose
This document is the authoritative living requirements specification for the SLE Digital Twin (SLE-DT) thesis project. New literature reviews, datasets, architectures, and biological findings shall be merged into this specification.

---

## Canonical Thesis Direction
### Selected MVP Architecture
**Transcriptomics-First + Molecular-Endotype-Aware Healthcare Digital Twin**

### Rationale
- SLE exhibits substantial molecular heterogeneity.
- Transcriptomics provides the strongest evidence base among reviewed sources.
- Molecular endotypes are repeatedly identified as important for precision medicine.
- Digital Twin architecture should be driven by the research objective rather than by a generic DT framework.
- The reviewed DT literature explicitly states that no universally optimal Digital Twin architecture exists.

### DT Classification Decision
Based on currently reviewed literature, the SLE-DT is best classified as a:
- Patient-specific healthcare Digital Twin.
- Immune-system focused Digital Twin.
- Research and discovery Digital Twin.
- Hypothesis-generation Digital Twin.

It is not currently intended to be:
- A clinical decision-support system.
- A regulatory-grade healthcare device.
- A metaverse-enabled healthcare platform.

---

## Executive Thesis Objective
Develop an explainable Digital Twin capable of:
- Modeling patient-specific immune dysregulation.
- Identifying disease-driving genes and pathways.
- Stratifying patients into molecular endotypes.
- Simulating restoration of immune tolerance.
- Prioritizing candidate therapeutic targets.
- Generating testable biological hypotheses.

---

## MVP Scope
### Included
- Public GEO transcriptomic datasets.
- Healthy reference twin.
- Patient-specific twin.
- DEG analysis.
- Pathway analysis.
- PPI network analysis.
- Molecular endotype discovery.
- Virtual perturbation simulations.
- Explainable target ranking.
- Technical and biological validation.

### Explicitly Excluded
- Wet-lab validation.
- Clinical deployment.
- Real-time patient monitoring.
- Wearables.
- Metaverse interfaces.
- VR environments.
- Multi-omics integration.
- Longitudinal digital-health integration.

---

## Architecture Evolution Roadmap
### Phase 1 (Current Thesis MVP)
- Transcriptomics.
- Endotype stratification.
- Healthy twin.
- Patient twin.
- Twin comparison.
- Perturbation engine.
- Target ranking.

### Phase 2
- Proteomics.
- Cytokines.
- Serology.
- Composite biomarkers.
- Treatment-response prediction.

### Phase 3
- Longitudinal twins.
- EHR integration.
- Wearables.
- Digital biomarkers.
- Drift monitoring.
- Continuous feedback loops.

### Phase 4
- Organ-specific twins.
- Multimodal healthcare twins.
- System-wide lupus twins.

---

## Scientific Foundation
### Immune Tolerance Restoration
Primary goal: restoration of immune homeostasis.

### Neutrophil Biology
Mandatory pathways:
- Neutrophil activation.
- Neutrophil-mediated immunity.
- Neutrophil degranulation.

### Interferon Biology
Mandatory pathway family:
- Type-I interferon signaling.

### Priority Hub Genes
- CCNB2
- CDCA8
- AURKB
- BUB1B
- RRM2
- BIRC5
- UBE2C

---

## Research Questions
### Primary
Can an explainable transcriptomic Digital Twin identify biological corrections that move an SLE immune state toward a healthy immune state?

### Secondary
- Which pathways drive disease-state deviation?
- Are neutrophil pathways dominant?
- Are interferon-based endotypes present?
- Which mechanisms are reproducible across cohorts?
- Which restoration hypotheses appear most biologically plausible?

---

## Data Strategy
### Core Datasets
- GSE162828
- GSE169080

### Future Sources
- ImmPort
- ArrayExpress
- Additional GEO datasets

### Dataset Requirements
Capture when available:
- Age
- Sex
- Ethnicity
- Disease subtype
- Clinical metadata

---

## Molecular Endotype Layer
Purpose:
- Discover biologically meaningful SLE subgroups.

Signals:
- Gene-expression similarity.
- Interferon activity.
- Pathway activity.
- Immune-state signatures.

Deliverables:
- Endotype definitions.
- Cluster descriptions.
- Endotype-specific targets.

---

## Biomarker Framework
### MVP
- DEGs.
- Pathway signatures.
- Hub genes.
- Endotype signatures.

### Future
- Proteomic biomarkers.
- Cytokine biomarkers.
- Serological biomarkers.
- Imaging biomarkers.
- Digital biomarkers.

---

## Digital Twin Architecture Requirements
### Functional Components
1. Data ingestion.
2. Preprocessing.
3. DEG engine.
4. Pathway engine.
5. Network engine.
6. Endotype engine.
7. Healthy twin.
8. Patient twin.
9. Twin comparison engine.
10. Perturbation engine.
11. Explainability engine.
12. Target ranking engine.

### Design Principle
Architecture must be application-driven and justified by SLE research objectives.

---

## Validation and Verification Framework
### Verification
- Pipeline correctness.
- Reproducibility.
- Stability.

### Biological Validation
Recover:
- Neutrophil pathways.
- Interferon pathways.
- Published hub genes.
- Literature-supported biomarkers.

### Digital Twin Validation Requirement
Validation shall be treated as a first-class requirement equal in importance to model development.

---

## Feedback Loop Requirements (NEW)
Although real-time feedback is outside the MVP, future architecture should support:
- Data refresh.
- Model recalibration.
- Performance monitoring.
- Decision traceability.

---

## Security and Governance Requirements (NEW)
### Privacy
- Public datasets only for MVP.
- No protected patient data.

### Governance
- Transparent model documentation.
- Explainable outputs.
- Bias review.

### Security
Future systems should support secure handling of health information and integrated data sources.

---

## Responsible AI Requirements
- TRIPOD+AI alignment.
- PROBAST+AI considerations.
- Population representation review.
- Fairness assessment.
- Drift monitoring roadmap.

---

## Open Research Questions
The reviewed literature does not answer the following questions.

1. Can deep learning outperform DEG-to-PPI workflows?
2. Which hub genes remain important under graph-learning models?
3. Can machine learning recover biologically meaningful genes filtered by traditional thresholds?
4. How accurately can transcriptomics alone predict therapeutic targets?
5. Are public longitudinal SLE cohorts available?
6. How should production Digital Twins implement drift monitoring?
7. Can subtype-specific twins outperform generalized SLE twins?
8. How should wearable-derived biomarkers be integrated?
9. Which public datasets contain both molecular and digital-health data?
10. What minimum biomarker set is necessary for a clinically useful lupus twin?
11. Has a fully customizable patient-specific SLE Digital Twin already been demonstrated?
12. Which healthcare Digital Twin category best aligns with lupus research goals?
13. Would an organ-specific lupus Digital Twin provide sufficient MVP value?
14. Should long-term architecture evolve toward system-wide or organ-specific twins?
15. Which lupus target organ would provide the highest-value future organ-level twin?
16. Are existing lupus organ-simulation platforms available?
17. Which biological, clinical, behavioral, and environmental variables are essential for a clinically meaningful Lupus-DT?
18. Which multidisciplinary stakeholders should participate in future development?

---

## Expected Thesis Contributions
- Explainable SLE Digital Twin architecture.
- Molecular-endotype-aware disease modeling.
- Immune tolerance restoration framework.
- Neutrophil-centric target prioritization.
- Validation-oriented healthcare DT methodology.
- Reproducible research platform.

---

## References (IEEE)
[1] Y. Zhao et al., "Identification of Biomarkers and Pathways in Systemic Lupus Erythematosus Through Integrated Bioinformatics Analysis," 2021.

[2] GSE162828, Gene Expression Omnibus.

[3] GSE169080, Gene Expression Omnibus.

[4] STRING Database.

[5] Cytoscape.

[6] M. E. Ritchie et al., limma.

[7] Artificial Intelligence, Biomarkers, and Precision Medicine in Autoimmune Inflammatory Rheumatic Diseases.

[8] Digital Twins and the Metaverse in Healthcare and Industry.
